Liminatus Pharma, Inc. (NASDAQ: LIMN) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT LIMINATUS PHARMA, INC.

Liminatus Pharma, Inc. (NASDAQ: LIMN)
Listen to this Section

$0.10
+0.0040 ( +4.04% ) 459.3K

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Market Data
Open $0.10
Previous Close $0.10
Volume 459.3K
Market Cap $5.01M
Day Range $0.10 - $0.10
52 Week Range $0.10 - $22.71
Shares Outstanding 50.61M
Change % +4.04%
Net Change ▲ 0.0040
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
IPO Year2025
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings

No data available for selected period.

Latest News

About US

Services

Stay Connected